{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Klukova L"],"funding":["Slovak Scientific Grant Agency","European Research Council","European Union’s Seventh Framework Programme for research, Technological Development and Demonstration","Slovak Research and Development Agency","ERDF"],"pagination":["555-562"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4883648"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["853"],"pubmed_abstract":["Systemic sclerosis (SSc) is an autoimmune disease seriously affecting patient's quality of life. The heterogeneity of the disease also means that identification and subsequent validation of biomarkers of the disease is quite challenging. A fully validated single biomarker for diagnosis, prognosis, disease activity and assessment of response to therapy is not yet available. The main aim of this study was to apply an alternative assay protocol to the immunoassay-based analysis of this disease by employment of sialic acid recognizing lectin Sambucus nigra agglutinin (SNA) to glycoprofile serum samples. To our best knowledge this is the first study describing direct lectin-based glycoprofiling of serum SSc samples. Three different analytical methods for glycoprofiling of serum samples relying "],"journal":["Analytica chimica acta"],"pubmed_title":["Glycoprofiling as a novel tool in serological assays of systemic sclerosis: a comparative study with three bioanalytical methods."],"pmcid":["PMC4883648"],"funding_grant_id":["311532","317420"],"pubmed_authors":["Klukova L","Petrikova M","Rovensky J","Imrich R","Tkac J","Kasak P","Mislovicova D","Mosnacek J","Andicsova-Eckstein A","Bertok T","Sediva A","Katrlik J","Vikartovska A","Filip J","Lukac J"],"additional_accession":[]},"is_claimable":false,"name":"Glycoprofiling as a novel tool in serological assays of systemic sclerosis: a comparative study with three bioanalytical methods.","description":"Systemic sclerosis (SSc) is an autoimmune disease seriously affecting patient's quality of life. The heterogeneity of the disease also means that identification and subsequent validation of biomarkers of the disease is quite challenging. A fully validated single biomarker for diagnosis, prognosis, disease activity and assessment of response to therapy is not yet available. The main aim of this study was to apply an alternative assay protocol to the immunoassay-based analysis of this disease by employment of sialic acid recognizing lectin Sambucus nigra agglutinin (SNA) to glycoprofile serum samples. To our best knowledge this is the first study describing direct lectin-based glycoprofiling of serum SSc samples. Three different analytical methods for glycoprofiling of serum samples relying ","dates":{"release":"2015-01-01T00:00:00Z","publication":"2015 Jan","modification":"2026-05-30T11:53:32.096Z","creation":"2019-03-27T02:14:41Z"},"accession":"S-EPMC4883648","cross_references":{"pubmed":["25467503"],"doi":["10.1016/j.aca.2014.10.029"]}}